VolitionRx Limited’s recently made public that its Director Faulkes Martin Charles acquired Company’s shares for reported $12436.0 on Aug 31. In the deal valued at $1.28 per share,9,716 shares were bought. As a result of this transaction, Faulkes Martin Charles now holds 1,673,532 shares worth roughly $ 2.16 million.
Then, Micallef Jacob Vincent bought 8,750 shares, generating $11,112 in total proceeds. Upon buying the shares at $1.27, the Chief Scientific Officer now owns 55,000 shares.
Before that, Micallef Jacob Vincent bought 11,250 shares. VolitionRx Limited shares valued at $13,950 were divested by the Chief Scientific Officer at a price of $1.24 per share. As a result of the transaction, Micallef Jacob Vincent now holds 46,250 shares, worth roughly $59662.5.
The Benchmark Company downgraded its VolitionRx Limited [VNRX] rating to a Hold from a a Buy in a research note published on Friday.
Price Performance Review of VNRX
On Friday, VolitionRx Limited [AMEX:VNRX] saw its stock jump 3.20% to $1.29. On the same session, the stock had its day’s lowest price of $1.23, but rose to a high of $1.30. Over the last five days, the stock has gained 4.88%. VolitionRx Limited shares have fallen nearly -46.91% since the year began. Nevertheless, the stocks have fallen -23.67% over the past one year. While a 52-week high of $2.74 was reached on 01/24/23, a 52-week low of $1.12 was recorded on 08/16/23. SMA at 50 days reached $1.3309, while 200 days put it at $1.7970. A total of 87999.0 shares were traded, compared to the trading of 78100.0 shares in the previous session.
Levels Of Support And Resistance For VNRX Stock
The 24-hour chart illustrates a support level at 1.2467, which if violated will result in even more drops to 1.2033. On the upside, there is a resistance level at 1.3167. A further resistance level may holdings at 1.3433. The Relative Strength Index (RSI) on the 14-day chart is 51.75, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.0176, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 10.53%. Stochastics %K at 75.44% indicates the stock is a holding.
How much short interest is there in VolitionRx Limited?
A steep rise in short interest was recorded in VolitionRx Limited stocks on Aug 14, 2023, growing by 50380.0 shares to a total of 0.82 million shares. Yahoo Finance data shows the prior-month short interest on Jul 13, 2023 was 0.77 million shares. There was a rise of 6.17%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 1.38% of the overall stock float, the days-to-cover ratio (short ratio) rose to 4.64.
VolitionRx Limited [VNRX] – Who Are The Largest Shareholders?
In filings from Lagoda Investment Management LP, it is revealed that the company now owns 3,929,110 shares, or roughly 6.22% of the outstanding VNRX shares. In other words, the investor’s shares have risen by 153,666 from its previous 13-F filing of 3775444.0. Additionally, BlackRock Fund Advisors increased 3.44% of its stake after which the total value it holdings stand at $748,358, while The Vanguard Group, Inc. added 2.93% of its stake to hold $0.68 million in the firm. Over the last quarter, Geode Capital Management LLC purchased 172,488 shares of VolitionRx Limited, while Morgan Stanley Smith Barney LLC bought -18,008 shares. At present, Cowen Prime Advisors LLC is holding 178,738 shares valued at $0.24 million. Bridgeway Capital Management LLC owned 176,100 shares of the company at the time of its most recent 13F filing, worth $0.24 million.